Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-09T22:43:51.204Z Has data issue: false hasContentIssue false
  • English
  • Français

RNA repair for haemophilia A

Published online by Cambridge University Press:  10 January 2006

Hengjun Chao  and
Christopher E. Walsh
Hengjun Chao
Affiliation:
Dept of Medicine, Division of Hematology and Medical Oncology, Mt Sinai School of Medicine, One Gustave Levy Place, Box 1079, New York, NY 10029, USA.
Christopher E. Walsh
Affiliation:
Dept of Medicine, Division of Hematology and Medical Oncology, Mt Sinai School of Medicine, One Gustave Levy Place, Box 1079, New York, NY 10029, USA.
Get access Rights & Permissions [Opens in a new window]

Abstract

The mainstay of gene transfer studies is the use of wild-type cDNAs to effect phenotypic correction of diseases. However, this strategy is not feasible for genetic diseases caused either by mutations of large genes or by dominant-negative mutations, or where the regulation of the gene is critical. In this review, we will discuss a novel RNA reprogramming strategy – spliceosome-mediated RNA trans-splicing – where the pre-messenger RNA is modified by the splicing of two independent RNA species. The use of trans-splicing to effect phenotypic change in the hereditary bleeding disorder haemophilia A will be discussed.

Keywords

trans-splicingspliceosomegene transferhaemophiliaAAVRNA
Type
Review Article
Information
Expert Reviews in Molecular Medicine , Volume 8 , Issue 1 , 10 January 2006 , pp. 1 - 8
Copyright
Cambridge University Press 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)